Paper123545
Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.
Eggers AE and 1 other. J Immunol, 1975. Cited by 105 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens. Papers, record 123545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/123545
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Neoplasms, Experimental | Major topic |
| Absorption | |
| Animals | |
| Antilymphocyte Serum | |
| Cell Line | |
| Chemical Fractionation | |
| Chromium Radioisotopes | |
| Cytotoxicity Tests, Immunologic | |
| Fibrosarcoma | |
| Fluorescent Antibody Technique | |
| Goats | |
| Immune Sera | |
| Immunosuppression Therapy | |
| Lymphocyte Culture Test, Mixed | |
| Lymphocytes | |
| Male | |
| Methylcholanthrene | |
| Mice | |
| Mice, Inbred AKR | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Nylons | |
| Radiation Effects | |
| Spleen | |
| T-Lymphocytes |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,046,454 | Radiation-induced augmentation of the response of A/J mice to SaI tumor cells. | Am J Pathol | 1982 | https://conductscience.org/library/papers/7046454 | PubMed |
| 6,737,802 | The role of the spleen in tumor bearing host: I. Characterization of spleen cells in tumor-bearing mice. | Jpn J Surg | 1984 | https://conductscience.org/library/papers/6737802 | PubMed |
| 6,350,312 | The seeding of a transplanted murine leukemia and its influence on hemopoietic stem cells and immune function of the host. | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6350312 | PubMed |
| 6,231,310 | Decreased T lymphocyte migration in patients with malignancy mediated by a suppressor cell population. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6231310 | PubMed |
| 6,139,161 | Cytotoxic T lymphocytes in DBA/2 mice harboring L5178Y cells in a tumor-dormant state. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6139161 | PubMed |
| 3,158,610 | Suppressive effect of secondary Toxoplasma gondii infection on antibody responses in mice. | Infect Immun | 1985 | https://conductscience.org/library/papers/3158610 | PubMed |
| 3,156,088 | Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma. | Immunology | 1985 | https://conductscience.org/library/papers/3156088 | PubMed |
| 1,082,135 | Different responses of lymphoid cells from tumor-bearing as compared to tumor-immunized mice when sensitized to tumor specific antigens in vitro. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1082135 | PubMed |
| 942,993 | Leukemia in AKR mice. I. Effects of leukemic cells on antibody-forming potential of syngeneic and allogeneic normal cells. | J Exp Med | 1976 | https://conductscience.org/library/papers/942993 | PubMed |
| 272,660 | Evidence that tumor antigens enhance tumor growth in vivo by interacting with a radiosensitive (suppressor?) cell population. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/272660 | PubMed |
| 154,982 | Suppression of lymphoproliferative responses to alloantigens by autologous AML cells. | Clin Exp Immunol | 1979 | https://conductscience.org/library/papers/154982 | PubMed |
| 153,914 | Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes. | J Clin Invest | 1979 | https://conductscience.org/library/papers/153914 | PubMed |
| 149,140 | Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. | J Clin Invest | 1978 | https://conductscience.org/library/papers/149140 | PubMed |
| 144,770 | Occurrence of restricted suppressor T-cell activity in man. | J Exp Med | 1977 | https://conductscience.org/library/papers/144770 | PubMed |
| 16,939 | Studies on the pathogenesis of an immune defect in multiple myeloma. | J Clin Invest | 1977 | https://conductscience.org/library/papers/16939 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/123545
GET https://conductscience.org/api/papers/v1/123545/authors